MedTrace Logo

Effect of Direct-acting Antiviral Drugs on Erectile Function

NCT03444272 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2020-10-22

No results posted yet for this study

Summary

Effect of direct-acting antiviral drugs on erectile function

Conditions

  • Hepatitis C

Interventions

DRUG

Sofosbuvir and Daklatasuvir

HCV Treatment (Sofosbuvir and Daklatasuvir)

Sponsors & Collaborators

  • Benha University

    collaborator OTHER

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Sherief Abd-Elsalam, MD · Tanta University

  • Mohamed Alhefnawy, MD · Tanta University Faculty of medicine

  • Khaled Almekaty, MD · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444272 on ClinicalTrials.gov